Navigation Links
Z Trim Holdings Abstract Selected as 'Best of the Best' by Institute of Food Technologists

Highlights Use of Soluble Fiber for Health & Wellness in Food Design and Reformulation at IFT '09 Expo

MUNDELEIN, Ill., June 3 /PRNewswire-FirstCall/ -- Z Trim Holdings, Inc. (OTC Bulletin Board: ZTHO), manufacturer of multifunctional fiber food ingredients, today announced its scientific abstract, Minimally Processed Soluble Dietary Fiber for Health and Wellness Foods Design and Reformulation, was selected as being among the "best of the best" abstracts submitted to the "New Products and Technologies" (NPT) sessions in the Ingredients category for the 2009 Institute of Food Technology's (IFT) 2009 Annual Meeting and Food Expo's Scientific Program.

Z Trim Holding's Executive Vice President of Manufacturing and Technology, Dr. Triveni Shukla, PhD., author of the abstract, will give an oral presentation in room 201AB at 11:50 a.m. PST on Tuesday, June 9 at the annual IFT meeting.

In conformance with the requirements of the program, the IFT NPT judging subpanel recognized that the abstract submission met the criteria of being new, incorporating a convincingly innovative new technology, and delivering improved performance over competitive items already available. The panel weighed the abstract's relevance against the following quality factors: degree of innovation, practical application of content, quality of abstract, scientific merit, pertinence to IFT member audience, and timeliness of science.

According to Dr. Shukla, "Our proprietary dietary fiber hydrcolloids have nano to macro scale functional attributes that enable or enhance design functions in food products for superior values."

These sessions typically generate much interest among product developers and manufacturing personnel who are looking for solutions to meet their needs.

News of the selection represents progress in Z Trim Holdings' forward looking approach. "Our selection underscores the degree of value we bring to our marketplace," said Z Trim Holdings CEO Steve Cohen. "As we continue to grow our own line of offerings, we look forward to working with our customers, and expanding on the solutions we can offer as we continue to develop our own market space," he said. "We are quite proud of the honor."


Z Trim Holdings, Incorporated,, partners with the food industry in the deployment of solutions and technologies built around cutting edge multifunctional dietary fibers, blends and custom emulsions. Innovation for health and wellness is built into our business model with value added components of capital, process, product, market, and R&D knowledge.

Z Trim(R) and Z Trim blends are functional food ingredients emulsifiers and stabilizers made from the hulls of either corn OR oat. Z Trim is versatile and can serve as a fat replacement, thickening agent or emulsifier with texturization, binding, shaping, suspension, water control and pH balance attributes. Z Trim represents a natural and frequently cost competitive alternative or complement to many of the oils, gums and starches it can replace. Because Z Trim is non-caloric dietary fiber, replacement of added fats with Z Trim can achieve up to 80% calorie reduction in many foods without negatively affecting taste or texture, and can substantially reduce harmful trans and saturated fats found in many foods. Z Trim has wide application in dairy products, dressings, dips, sauces, baked goods, processed meats, snack foods, cookies, pies, cakes, icings, brownies, bars, ice cream, milk shakes and many other foods.

Forward-Looking Statements and Risk Factors

Certain statements in this press release are "forward¿looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of Z Trim Holdings to be materially different from any future results, performance or achievements expressed or implied by these forward¿looking statements. Other factors, which could materially affect such forward¿looking statements, can be found in our filings with the Securities and Exchange Commission at, including risk factors relating to our history of operating losses, that our auditors have expressed substantial doubt regarding our ability to continue as a going concern, the fact that we may dilute existing shareholders through additional stock issuances, and our reliance on our intellectual property. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward¿looking statements and are cautioned not to place undue reliance on such forward¿looking statements. The forward¿looking statements made herein are only made as of the date of this press release and we undertake no obligation to publicly update such forward¿looking statements to reflect subsequent events or circumstances.

    Contacts:   Phil Versten (Media)        Angela Strickland (Investors)
                (847) 549-6002              (847) 549-6002

SOURCE Z Trim Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NXGen Holdings, Inc. Enters the $17.5 Billion Household and Industrial Cleaning Products Industry through the Acquisition of Green Bridge Industries, Inc.
2. SETO Holdings, Inc. Signs Agreement to Acquire Advanced Hearing Centers, Inc. and Will Dispose of All Existing Business; New Management to be Installed
3. LifeCare Holdings, Inc. Announces First Quarter Results
4. China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results and Corporate Updates
5. HMS Holdings Corp. to Present at 2009 Deutsche Bank Healthcare Conference
6. Zimmer Holdings to Present at Deutsche Bank 34th Annual Health Care Conference
7. Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting
8. HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
9. China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
10. InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009
11. Duane Reade Holdings, Inc. Reports First Quarter 2009 Results
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... For the millions of people who use ... launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister Continence Care ... portfolio,” said Michael Gresavage, Vice President North America. "We designed our VaPro Plus ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:11/30/2015)... ... November 30, 2015 , ... Third ... today that it has officially launched a sleek, mobile-ready and user-centric redesigned website. ... company’s new website clearly outlines the benefits that its SEO services provide to ...
(Date:11/30/2015)... ... , ... The National Association of Professional Women (NAPW) honors ... Circle. She is recognized with this prestigious distinction for leadership in estate sales and ... than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... Injectables, Topical Contraceptives, Male Condoms, Female Condoms, ... Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent ... Share, Growth, Trends and Forecast 2014 - ... Market Research (TMR).The report states that the ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology: